The MarketReader Minute
💊BioNTech Gains Momentum with FDA’s Green Light on HER3 Trial, While Regeneron Soars to New Heights Amid Industry Challenges | Biotech Sector Insights
The top contributors to this performance include UTHR, which experienced a significant rise, contributing the most to the ETF's performance. MRNA and VRTX also posted modest gains, with each making a smaller contribution.